drugset / Trial / NCT02644447
Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF
Phase 1/2
Completed
23 enrolled
Chinese Academy of Sciences
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Cellular therapies are rapidly progressing fields and have shown immense promise in the treatment of damaged ovarian function. The purpose of this study is to determine safety and efficacy of intra-ovarian injection of allogeneic HUC-MSCs with injectable collagen scaffold in women with Premature Ovarian Failure (POF) and to study the preliminary efficacy of HUC-MSCs with injectable collagen scaffold injection on ovarian function improvement.
Timeline
- Start
- 2015-10
- Primary completion
- 2018-10
- Completion
- 2018-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HUC-MSCs with Injectable Collagen Scaffold | Unknown | 1e+07 cells | Other |
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 1e+07 cells | Other |